Browsing: Pluvicto

Top Line: Should Pluvicto be added to ADT and an androgen receptor pathway inhibitor for metastatic, castration sensitive prostate cancer?…

Top Line: Can Pluvicto delay the need for ADT in men with oligometastatic, hormone sensitive prostate cancer with rapid PSA…

Both Xofigo (Radium-223) and Pluvicto (Lutetium-177 PSMA) are used in the treatment of metastatic, castration resistant prostate cancer. In the…

Top Line: Do quantitative PSMA PET parameters predict response to Pluvicto?The Study: You need a positive PSMA PET to administer…

A retrospective look at men on an androgen receptor pathway inhibitor (ARPI) for metastatic castrate-resistant prostate cancer demonstrates roughly half…

Top Line: Does Pluvicto improve survival in patients with mCRPC who progress on an androgen receptor pathway inhibitor?The Study: In…

Top Line: A shortage of Pluvicto has led Novartis to halt new patient starts in order to supply patients actively…